Key result
A positive echocardiogram combined with elevated NT-proBNP was associated with a 12-fold elevation in complication risk compared with patients with low NT-proBNP.
Why the study?
Does the combination of NT-proBNP or troponin testing with echocardiography improve risk stratification for death or major in-hospital complications in patients with acute pulmonary embolism?
Observational (n=124)
Does the combination of NT-proBNP or troponin testing with echocardiography improve risk stratification for death or major in-hospital complications in patients with acute pulmonary embolism?
Combining NT-proBNP or troponin testing with echocardiography effectively risk-stratifies patients with acute pulmonary embolism, identifying those at highest risk for in-hospital complications.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in acute PE; hypothesis-generating and requires prospective validation before guiding care.
BACKGROUND: Brain natriuretic peptide (BNP) and N-terminal (NT)-proBNP have recently emerged as promising parameters for risk assessment in acute pulmonary embolism (PE). However, their positive predictive value is low, and the prognostic implications of NT-proBNP or troponin elevation alone are questionable. METHODS AND RESULTS: To determine whether the combination of NT-proBNP testing with echocardiography may identify both low-risk and high-risk patients with PE, we examined 124 consecutive patients with proved PE. All underwent echocardiography on admission to detect right ventricular dysfunction. NT-proBNP and troponin concentrations were measured in one core laboratory. The primary end point was death or major in-hospital complications. The cutoff level of 1000 pg/mL had a high negative predictive value (95% for a complicated course, 100% for death), but NT-proBNP > or =1000 pg/mL did not independently predict an adverse outcome. Combination of NT-proBNP testing with echocardiography identified 3 major risk groups. A positive echocardiogram was associated with a 12-fold elevation in complication risk compared with patients with low NT-proBNP (P=0.002), whereas NT-proBNP elevation without right ventricular dysfunction on echocardiography only slightly increased the risk of an adverse outcome (P=0.17). The combination of cardiac troponin testing with echocardiography yielded similar complication rates in the lowest-risk group and a similar magnitude of risk elevation for the highest-risk patients, but it also increased the number of intermediate-risk groups. CONCLUSIONS: Our results support a simple risk stratification algorithm for patients with PE, with the use of NT-proBNP or troponin testing as an initial step that should be followed by echocardiography if elevated levels of the biomarker are found.
No takes yet. Share an insight, caveat, or question.
Binder et al. (2005) conducted an observational in Acute pulmonary embolism (n=124). Elevated NT-proBNP with positive echocardiogram vs. Low NT-proBNP was evaluated on Death or major in-hospital complications (12-fold elevation in risk, p=0.002). A positive echocardiogram combined with elevated NT-proBNP was associated with a 12-fold elevation in complication risk compared with patients with low NT-proBNP.
Synapse has enriched 10 related papers. Consider them for comparative context: